Radiosensitivity Enhancement using Triptorelin Conjugated Bismuth Sulfide Nanoparticles (Bi₂S₃@BSA) in Radiotherapy for Breast Cancer Cells

Figure 2

(a) TEM image of Bi₂S₃@BSA NPs, (b) and (c) size distribution and (d) and (e) zeta potential of Bi₂S₃@BSA NPs and Bi₂S₃@BSA–triptorelin NPs, (f) and (g) shows zeta potential and size distribution of Bi₂S₃ NPs.

(a)

(b)

(c)

(d)

(e)

(f)

(g)